Cargando…
Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines
BACKGROUND: Lapatinib is a dual epidermal growth factor receptor (EGFR) and HER2 inhibitor. Overexpression of these receptors is frequently observed in head and neck squamous cell carcinoma (HNSCC). As growing proportion of HNSCC is characterized by human papillomavirus (HPV) infection, we aimed at...
Autores principales: | Fumagalli, Ingrid, Dugue, Delphine, Bibault, Jean Emmanuel, Clémenson, Céline, Vozenin, Marie Catherine, Mondini, Michele, Deutsch, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322874/ https://www.ncbi.nlm.nih.gov/pubmed/25678800 http://dx.doi.org/10.2147/OTT.S68235 |
Ejemplares similares
-
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation
por: Meziani, Lydia, et al.
Publicado: (2023) -
Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib
por: Gandhi, Mitul D, et al.
Publicado: (2014) -
Survivin in Insulin-Like Growth Factor-Induced Resistance to Lapatinib in Head and Neck Squamous Carcinoma Cells
por: Lehman, Christine E., et al.
Publicado: (2019) -
Impact of human papillomavirus on head and neck squamous cell cancers in Gabon
por: Ingrid, Labouba, et al.
Publicado: (2015) -
Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib
por: Strickley, John D., et al.
Publicado: (2018)